Histological evidence shows that 84% of CKD patients have bone disorders.73 Bone metabolism is regulated by several factors including parathormona (PTH), fibroblast growth factor 23 (FGF23), and dihydroxycholecalciferol (1,25(OH)2D). The gene discussed is FGF23; the disease is bone disorder.